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T
he number of children 
worldwide with hearing 
impairment is increasing, 
and these children face a number 
of obstacles and burdens, given that 
spoken language is the predominant 
medium of communication and 
social interaction. Adequate auditory 
stimulation, in early childhood 
in particular, is the foundation 
for optimal speech and language 
development as well as the acquisition 
of literacy skills [1,2]. Failure to detect 
early and effectively manage within the 
ﬁ  rst year of life a permanent hearing 
impairment that is congenital or that 
originates in the neonatal period has 
been associated with signiﬁ  cant and 
irreversible deﬁ  cits in speech and in 
linguistic, cognitive, and educational 
development [3,4].
In recognition of the growing 
and signiﬁ  cant burden of hearing 
impairment globally, the World Health 
Assembly (WHA) in 1995 passed a 
resolution on the prevention and 
control of major causes of avoidable 
hearing impairment and on early 
detection in “babies, toddlers, and 
children” within the framework of 
primary health care [5]. The WHA 
is made up of ministers of health of 
United Nations member states and is 
responsible for determining the policies 
of the World Health Organization 
(WHO) to reﬂ  ect the preferences of 
the UN member states [6].
Although neonatal hearing 
screening of all infants has become 
a standard of public health care in 
developed countries, the current 
priorities of major global health 
actors such as the World Bank and 
the United Nations Children’s Fund 
(UNICEF) have yet to address the 
needs of infants with lifelong hearing 
impairment in developing countries 
[7,8]. Considering the substantial 
inﬂ  uence of global health priorities 
on government programs in many 
developing countries, this exclusion is 
likely to prevent vital public investment 
into early hearing detection services 
for an estimated 718,000 babies born 
annually in these countries [8,9]. This 
article therefore examines the current 
proﬁ  le of global health-care ﬁ  nancing 
and the opportunities for promoting 
this essential, time-bound health 
intervention in developing countries.
The Global Burden of Childhood 
Hearing Impairment
The WHO global estimate for disabling 
hearing impairment (of a degree of 
severity >40 dBHL) has more than 
doubled from 120 million people in 
1995 to at least 278 million in 2005 
[10]. Two-thirds of individuals with 
hearing impairment live in developing 
countries, and hearing impairment 
in 68 million people is estimated 
to have originated from childhood 
[10]. About two to four babies per 
1,000 live births are born annually in 
developed countries with permanent or 
sensorineural hearing impairment and 
this range may extend to six per 1,000 
live births within the neonatal period 
in developing countries [9]. Permanent 
hearing impairment is an etiologically 
heterogeneous trait attributable to 
genetic and environmental causes, half 
of which are probably preventable [10].
Primary prevention—through 
immunization, health education, 
and improved maternal and child 
health services—is useful for 
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preventing environmental causes 
of neonatal hearing impairment. 
But such prevention services have 
limited effectiveness in preventing 
the full spectrum of neonatal hearing 
impairment attributable to genetic 
or hereditary etiologies. Given the 
average life expectancy of 65 years 
in developing countries and 79 years 
in developed countries [8], lifelong 
hearing impairment is undoubtedly of 
great cost to society [11].
Current Trends in Global Health 
Care Financing
Every government has a duty to 
provide health care for its population. 
In many developed countries health-
care services (including universal 
newborn hearing screening [UNHS]) 
are freely provided, although some 
individuals may opt for private health 
services. The free provision of UNHS 
in many developed countries perhaps 
underpins the expectation that such 
screening should also be publicly 
funded in developing countries. But 
most governments are unable to wholly 
ﬁ  nance such programs, given the 
competing demands from prevailing 
communicable and fatal diseases, and 
thus have to seek external support. 
Early hearing detection from birth 
has been noted as an important and 
achievable goal for all countries 
[12]. But the failure to recognize 
childhood hearing impairment as 
a signiﬁ  cant health condition for 
developing countries at the global level 
diminishes the prospects for publicly 
funded UNHS programs and may also 
divert attention away from the critical 
role of governments in facilitating 
private sector–led initiatives for the 
development of requisite services.
The World Bank’s latest data on 
global spending for health care reveals 
striking variations in global health 
ﬁ  nancing, as shown in Table 1 [13]. 
In 2002, public share of total health 
expenditures (a measure of how 
actively governments intervene to 
ensure the ﬁ  nancing of public health 
services) ranged from 65% in high-
income countries and 42% in middle-
income countries to 29% in low-income 
countries. Global external funding 
accounted for 18% of total health 
expenditure in sub-Saharan Africa, 
3% in South Asia, and 8% of total 
expenditure in low-income countries as 
a whole [13].
Moreover, user fees are commonly 
charged for most health-care services 
in developing countries. Such user fees 
result in out-of-pocket spending of 93% 
of private expenditure in low-income 
countries (more than 60% of total 
health expenditure) and about 85% 
in middle-income countries (40% of 
total health expenditure), compared 
to 56% in high-income countries (20% 
of total health expenditure). On a 
regional basis, the share of government 
contribution to health expenditure is 
lowest in South Asia, with private and 
out-of-pocket spending accounting 
for at least 75% (Figure 1). Although 
out-of-pocket spending is generally 
viewed as inequitable, it has remained 
the norm for health ﬁ  nancing in most 
parts of the developing world and the 
situation is unlikely to change in the 
near future [13]. This trend therefore 
raises a fundamental question as to 
what extent local health-care priorities 
and services should be controlled by 
the policies of government or global 
health institutions.
Mechanisms for Financing Early 
Hearing Detection
Various levels of government 
determine public health priorities, 
taking into account the proportion of 
total revenue available for health care. 
Because resources are limited, public 
spending in low-income countries 
tends to be entirely concentrated on 
sustaining health systems rather than 
providing intervention services. As 
governments have to rely on additional 
funds from external sources, national 
priorities are therefore commonly 
guided (and sometimes overwhelmed) 
by diverse interests of multilateral 
institutions (World Bank, UNICEF, 
WHO, etc.) and donor partners despite 
their modest contributions to total 
health expenditure (Table 1) [14].
Given the substantial contributions 
of out-of-pocket spending to total 
national health expenditure, individual 
health preferences cannot be 
overlooked. Therefore, the key players 
in determining services to be provided 
are individual governments (national, 
state, or district), multilateral/donor 
agencies, and private providers, 
independently or in partnership. The 
factors that inﬂ  uence the priorities 
of these players and their relevance 
to services for early detection of 
childhood hearing impairment are now 
examined brieﬂ  y.
Government. Musgrove identiﬁ  ed 
up to nine criteria for determining 
public expenditure, grouped into 
economic efﬁ  ciency, ethical reasons, 



















Bangladesh, India, Pakistan, 
Nepal, Nigeria, Kenya, Haiti, 
Ghana (59)
29 71 27 8 93 66
Lower-middle income 
($826–$3,255)
Brazil, Cuba, Indonesia, 
Philippines, Syria, Jordan, 
Thailand, China (54)
42 58 2 0.9 86 50
Upper-middle income 
($3,256–$10,065)
Argentina, Botswana, South 
Africa, Mexico, Malaysia (33)
56 44 0.8 0.4 83 37
High income 
(>$10,065)
Brunei, Puerto Rico, Saudi 
Arabia, Kuwait, Qatar, 
United States, Japan, United 
Kingdom (15)
65 35 0.05 0.03 56 20
Data derived from [13].
GNI, gross national income
doi:10.1371/journal.pmed.0040074.t001
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and political considerations as shown 
in Box 1 [15]. He argued that the 
decision as to which health services 
to spend public money on requires a 
systematic consideration of all nine 
criteria. But what constitutes partial 
or full satisfaction of these individual 
criteria, or what combination of 
partial satisfaction of the criteria 
would make screening justiﬁ  able 
was not stated explicitly. However, 
political considerations often have 
overriding inﬂ  uence over any 
technical considerations for the choice 
of services and the level of allocated 
public spending. Governments may 
favor services that are less costly rather 
than services that are more cost-
effective because of the difﬁ  culty in 
accurately quantifying the beneﬁ  ts of 
services besides reduction in mortality.
Alternatively, the decision to embark 
on screening services, for instance, 
may be entirely predicated on the 
extent to which the conventional 
criteria for screening have been met 
[16], particularly when such costs 
can be (partly or fully) recovered 
through a ﬁ  nancing scheme like health 
insurance or user fees. Sometimes 
the best screening option from a 
medical perspective is not the most 
cost-effective or the most favorable 
in economic terms. Pilot studies are 
valuable in deciding the actual trade-
offs that need to be made among the 
various considerations.
Multilateral/donor organizations. 
The criteria for judging which 
interventions should be funded by 
donor agencies are often not explicit. 
However, the World Bank and WHO 
place emphasis on the burden of 
disease and on cost-effectiveness 
analyses of available interventions in 
setting health priorities [7].
Traditionally, burden of disease is 
measured by mortality or case fatality, 
which overlooks the full spectrum 
of the consequences of diseases on 
individuals or society. For instance, 
both communicable and chronic 
noncommunicable diseases are 
associated with signiﬁ  cant physical 
and functional disabilities that are 
mostly lifelong. In order to address 
this conceptual limitation, a summary 
population measure such as disability-
adjusted life years (DALYs) or its 
variant—quality-adjusted life years 
(QALYs)—is preferred. The World 
Bank and WHO maintain a database 
on the burden of disease for a variety 
of health conditions, which is used for 
cost-effectiveness analysis of various 
health interventions to establish 
priorities for developing countries 
[7]. This database is supplemented 
with available published evidence on 
the cost-effectiveness of interventions 
for diseases that are considered 
“important” by the UN agencies for 
global health.
However, this approach to global 
health ﬁ  nancing may be biased against 
early childhood hearing impairment 
in developing countries for a number 
of reasons. Firstly, there is no data on 
DALYs associated with this category 
of hearing impairment. The Global 
Burden of Disease database only 
addresses hearing impairment of adult 
onset while treating childhood-onset 
hearing impairment as sequelae of 
other diseases. Secondly, a signiﬁ  cant 
number of diseases and health 
conditions associated with early 
childhood hearing impairment were 
not considered in the report. Thirdly, 
without information on DALYs it is 
impracticable to evaluate the cost-
effectiveness of available effective 
interventions to allow for comparison 
with other diseases contained in the 
Global Burden of Disease report. 
Fourthly, DALYs are difﬁ  cult to 
compute where there is a scarcity of 
sound epidemiological data on the 
morbidity pattern of diseases, especially 
in developing countries. The use of 
DALYs has therefore been considered 
unsatisfactory for health planning in 
many developing countries and is rarely 
applied in practice [17,18].
While measuring the cost-
effectiveness of infant hearing 
screening compared to other 
child health interventions may be 
impracticable, the cost-effectiveness 
analysis of identifying a child with 
congenital hearing impairment can be 
reliably undertaken. Such an analysis 
would allow us to compare various 
intervention options such as targeted 
versus universal screening [19], one-
stage versus multistage screening [20], 
or hospital-based versus community-
based screening [21].
While cost-effectiveness analysis is 
currently the cornerstone of investment 
priorities in health care by the World 
Bank and its partners, the relevance of 
political, ethical, and cultural factors 
has also been acknowledged as equally 
important in allocating resources to 
speciﬁ  c diseases and interventions [7]. 
However, it would appear that WHA 
resolutions have little or no inﬂ  uence 
in this process despite their collective/
representative legitimacy [22]. This 
trend needs to be reviewed to make 
the current prioritization approach 
more equitable and less contentious. 
In this regard it would be valuable to 
encourage and support all governments 
to undertake epidemiological studies 
using the existing WHO ear care survey 
protocol. Such baseline data can then 
serve as a guide for local systematic 
capacity-building for early detection 
and intervention services.
Private and nongovernmental 
organizations. Private provision of 
services is often directed to satisfy 
identiﬁ  ed needs of individuals and 
communities neglected by other service 
providers. However, the way individuals 
choose to order their spending 
priorities is often unpredictable 
and complex. For instance, in some 
communities socially stigmatized 
diseases may be considered more 
important than nonstigmatized diseases 
even if they are less prevalent or more 
costly to treat [23]. In a growing 
number of developing countries, 
including Brazil, China, Oman, Saudi 
Box 1. Criteria for Prioritizing 
Health Expenditure
World Bank/WHO [7]
•  Burden of Disease
o Mortality 
o DALYs
• Cost-Effectiveness  Analysis




• Public  Goods
• Externalities
• Catastrophic  Cost
Ethical
• Horizontal  Equity
• Vertical  Equity
• Poverty
•  Rule of Rescue
Political
• Public  Demands
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Arabia, Iran, and the Philippines, 
newborn hearing screening services 
are offered for a fee in private and 
public hospitals under various small 
pilot programs. The emerging evidence 
accords with the prevailing pattern 
of health-care spending in general, 
which suggests that the value attached 
to health services cannot be judged 
solely by the level of public funding 
available for such services. In fact, 
it is not unusual to ﬁ  nd that some 
indigent parents view helping their 
disadvantaged children as a vital 
investment towards their own future 
ﬁ  nancial security and are thus willing 
to borrow or make the utmost ﬁ  nancial 
sacriﬁ  ces to obtain the needed services. 
Health priorities must therefore 
reﬂ  ect important sociocultural factors 
relevant to the target population and 
the willingness of individuals to take 
advantage of effective time-bound 
health interventions from their 
personal albeit limited resources.
Public–private partnership. 
The inability of governments to 
cater for diverse health needs with 
limited budgets has led to a growing 
trend towards local public–private 
partnerships for health-care delivery 
in low- and middle-income countries, 
especially for the most vulnerable 
populations [24,25]. For instance, a 
global partnership under the aegis 
of WWHearing (Worldwide Hearing 
Care for Developing Countries) is 
currently working with WHO towards 
the provision of affordable hearing 
aids and services to governments in 
developing countries (see http:⁄⁄www.
who.int/pbd/deafness/activities/
WWHearing/en/index.html). 
In addition, notable charitable 
organizations such as Christoffel-
Blindenmission, Lions Club 
International, and Rotary International 
already have networks for supporting 
individuals with hearing impairment 
in many developing countries, which 
can be channeled towards early 
hearing detection services. In such 
partnerships, the role of government 
is geared towards creating an enabling 
environment for private participation 
at various levels. This includes policy 
formulation in line with best practices, 
monitoring and control, and provision 
of ﬁ  scal incentives as well as human 
resource training and development. 
Public education on preventable 
causes of hearing impairment, such as 
ototoxic drugs and consanguineous 
unions, is also feasible and inexpensive. 
Private participation may also take 
place through the activities of local 
nongovernmental organizations or 
commercial service providers. Most 
nongovernmental organizations 
operate on a not-for-proﬁ  t basis but 
may charge modest fees to cover 
operational costs. Partnerships are most 
valuable and thrive where traditional 
ways of working independently have a 
limited impact on a problem and where 
core competencies or expertise of the 
parties are complementary [24].
Emerging evidence from ongoing 
pilot programs in countries such 
as Nigeria, South Africa, Malaysia, 
Brazil, and Poland demonstrate the 
effectiveness of different models 
of service delivery through public–
private partnerships. However, the 
sustainability of these initiatives may 
be undermined by the continued 
lack of public sector support and the 
overwhelming preoccupation with 
fatal diseases by major actors in global 
health. Since infant hearing screening 
is now routinely provided in developed 
countries, failure to extend such a 
program to developing countries where 
about 90% of children with permanent 
hearing impairment live will only 
exacerbate health inequalities between 
the rich and poor nations of the world. 
WHO also acknowledges that it is 
important to ensure that screening 
interventions aimed at diseases in 
developed countries should be made 
available to developing countries where 
these conditions have emerged as 
important health problems [26].
Ethical Considerations for Early 
Hearing Detection
The moral imperatives for providing 
early hearing intervention services, 
even in the absence of data on the cost-
effectiveness of available interventions 
relative to other diseases, have been 
discussed in greater detail elsewhere 
[27]. A few points are worth restating.
Firstly, the effectiveness of 
interventions for optimal outcomes in 
speech, language, and cognitive skills 
is limited to the ﬁ  rst year of life [3,4]. 
Secondly, if an apparently well child 
has a hidden abnormality, detectable 
at birth, that will most likely become 
obvious at an age when the prospects 
for effective intervention will have 
signiﬁ  cantly diminished, parents 
will want to have this information 
as soon as it is practically possible 
[28–30]. Thirdly, declaring a child with 
congenital hearing impairment as “well 
and normal” at discharge after routine 
neonatal examination without simple 
and quick hearing screening tests can 
be morally disturbing for health-care 
professionals, especially when parents 
are willing to pay for such services if 
required. The new UN Convention on 
the rights of persons with disabilities 
should provide a further moral impetus 
for all to act [31].
Some have argued that if cost-
effectiveness analysis is to have a larger 
role in health-care policy, an attempt 
must be made either to convince the 
public of its often overriding inﬂ  uence 
or to balance a consideration of its 
merits with a greater concern for 
equity [32]. Every government owes 
its citizens the right to be educated on 
best practices in health-care delivery, 
regardless of the limitations of public 
funding to deliver such services. 
This is a moral obligation. From 
this standpoint, parents should be 
educated on the current possibilities 
in early detection and intervention for 
early childhood hearing impairment 
regardless of the parents’ ﬁ  nancial 
status or the government’s ability 
to provide the requisite services. 
Additionally, while it is unethical to 
withhold infant hearing screening in 
places where rehabilitation services are 
poor, it is also ethically questionable 
to continue screening without any 
systematic effort to improve relevant 
intervention services, including 
community support for individuals with 
hearing impairment.
Conclusions
Current global health priorities 
for developing countries have 
yet to pay attention to the WHA 
resolution on hearing impairment, 
which acknowledges this condition 
in early childhood as a signiﬁ  cant 
health problem. The prospects of 
any immediate action are uncertain, 
since vital data required by the 
current approaches to global disease 
prioritization are scarce and of limited 
value where available. Although 
external assistance constitutes a small 
proportion of total health expenditure 
in low- and middle-income countries, 
the priorities of multilateral/donor 
organizations still have a great 
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inﬂ  uence on national health priorities 
and public sector–led systematic 
investment in requisite capacity-
building for early hearing detection 
and intervention services. There is an 
urgent need therefore to stimulate 
public–private partnerships to preserve 
the collective/representative legitimacy 
of WHA resolutions, recognize 
individual health preferences through 
out-of-pocket spending, and ensure that 
those willing to take advantage of time-
bound interventions for permanent 
and early-onset hearing impairment 
are not unduly disenfranchised by its 
current omission in the global health 
agenda for developing countries.  
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